The following is an edited excerpt.
Researchers at the Harris Birthright Centre at King’s College in London developed a test which analyzes a baby’s DNA via the mother’s blood to determine chromosomal disorders.
Currently, pregnant women who want to determine if their unborn child will have any genetic diseases need to endure invasive procedures like an amniocentesis that might put the baby at risk. The new method, published in the Ultrasound in Obstetrics & Gynecology journal, may provide a much safer way of testing.
Read the full story here: New Blood Test Detects Down Syndrome, Less Invasive than Current Methods
